Policy / Pricing Scientists issue call to arms over antifungal resistance PharmaphorumInfectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.Policy / PricingInfectious DiseaseRead full story pharminent April 15, 2026 Pharmaphorum Infectious disease experts from around the world are calling for concerted action to combat a “silent surge” in resistance to antifungal drugs. Policy / PricingInfectious DiseaseRead full story Post navigation Previous: S16 Ep52: Medical Crossfire: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical ApplicationNext: Whitepaper: CDMOs at a Crossroads Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
